Home - Products - Others - Other Targets - N6-(p-Hydroxyphenethyl)-Adenosine)

N6-(p-Hydroxyphenethyl)-Adenosine)

CAS No. 41552-94-7

N6-(p-Hydroxyphenethyl)-Adenosine)( —— )

Catalog No. M28547 CAS No. 41552-94-7

N6-(p-Hydroxyphenethyl)-Adenosine) is an adenosine analogue.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 29 In Stock
10MG 29 In Stock
25MG 51 In Stock
50MG 75 In Stock
100MG 112 In Stock
200MG Get Quote In Stock
500MG 276 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    N6-(p-Hydroxyphenethyl)-Adenosine)
  • Note
    Research use only, not for human use.
  • Brief Description
    N6-(p-Hydroxyphenethyl)-Adenosine) is an adenosine analogue.
  • Description
    N6-(p-Hydroxyphenethyl)-Adenosine) is an adenosine analogue.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    TAZ
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    41552-94-7
  • Formula Weight
    387.39
  • Molecular Formula
    C18H21N5O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    N(CCC1=CC=C(O)C=C1)C2=C3C(N(C=N3)[C@@]4(O[C@H](CO)[C@@H](O)[C@H]4O)[H])=NC=N2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jang EJ, et al. TM-25659 enhances osteogenic differentiation and suppresses adipogenic differentiation by modulating the transcriptional co-activator TAZ. Br J Pharmacol. 2012 Mar;165(5):1584-94.
molnova catalog
related products
  • Phenylglyoxylic acid

    Phenylglyoxylic acid is a metabolite of ethylbenzene and styrene.

  • ANP (1-30), frog

    ANP (1-30), frog

  • ShK-Dap22

    Extremely potent KV1.3 channel blocker (Kd = 23 pM for mKV1.3 currents). Selective for KV1.3 over other mammalian potassium channels (IC50 values are 23, 1800, 10500, 37000 and 39000 pM for mKV1.3, mKV1.1, hKV1.6, mKV1.4 and rKV1.2 respectively, and >100000 pM for hKV1.5, mKV1.7, hKV3.1, rKV3.4 and hKCa4). Suppresses T cell activation in vitro (IC50 < 500 pM).